Cargando…

Design, Synthesis and Cellular Characterization of a Dual Inhibitor of 5-Lipoxygenase and Soluble Epoxide Hydrolase

The arachidonic acid cascade is a key player in inflammation, and numerous well-established drugs interfere with this pathway. Previous studies have suggested that simultaneous inhibition of 5-lipoxygenase (5-LO) and soluble epoxide hydrolase (sEH) results in synergistic anti-inflammatory effects. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meirer, Karin, Glatzel, Daniel, Kretschmer, Simon, Wittmann, Sandra K., Hartmann, Markus, Blöcher, René, Angioni, Carlo, Geisslinger, Gerd, Steinhilber, Dieter, Hofmann, Bettina, Fürst, Robert, Proschak, Ewgenij
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155600/ https://www.ncbi.nlm.nih.gov/pubmed/28036068 http://dx.doi.org/10.3390/molecules22010045

Ejemplares similares

Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
por: Göbel, Tamara, et al.
Publicado: (2019)

Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast
por: Schierle, Simone, et al.
Publicado: (2019)

Soluble epoxide hydrolase limits mechanical hyperalgesia during inflammation
por: Brenneis, Christian, et al.
Publicado: (2011)

Inhibitors of Human 5-Lipoxygenase Potently Interfere With Prostaglandin Transport
por: Kahnt, Astrid S., et al.
Publicado: (2022)

Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase
por: Garscha, Ulrike, et al.
Publicado: (2017)

Soluble Epoxide Hydrolase in Atherosclerosis
por: Wang, Yi-Xin Jim, et al.
Publicado: (2010)

Inhibition of the Soluble Epoxide Hydrolase Promotes Albuminuria in Mice with Progressive Renal Disease
por: Jung, Oliver, et al.
Publicado: (2010)

Soluble Epoxide Hydrolase and Diabetes Complications
por: Anita, Natasha Z., et al.
Publicado: (2022)

Inhibition of Soluble Epoxide Hydrolase for Renal Health
por: Liu, Jun-Yan
Publicado: (2019)

Soluble Epoxide Hydrolase and Brain Cholesterol Metabolism
por: Domingues, Michelle Flores, et al.
Publicado: (2020)

Discovery of the first dual inhibitor of the 5-lipoxygenase-activating protein and soluble epoxide hydrolase using pharmacophore-based virtual screening
por: Temml, Veronika, et al.
Publicado: (2017)

Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγ
por: Kilu, Whitney, et al.
Publicado: (2021)

Evaluation of fish models of soluble epoxide hydrolase inhibition.
por: Newman, J W, et al.
Publicado: (2001)

Disrupting Dimerization Translocates Soluble Epoxide Hydrolase to Peroxisomes
por: Nelson, Jonathan W., et al.
Publicado: (2016)

Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
por: Imig, John D., et al.
Publicado: (2020)

The role of soluble epoxide hydrolase and its inhibitors in depression
por: Borsini, Alessandra
Publicado: (2021)

Design of dual ligands using excessive pharmacophore query alignment
por: Moser, Daniel, et al.
Publicado: (2012)

Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors
por: Kodani, Sean D., et al.
Publicado: (2018)

Effects of Soluble Epoxide Hydrolase Deficiency on Acute Pancreatitis in Mice
por: Bettaieb, Ahmed, et al.
Publicado: (2014)

Inhibition of soluble epoxide hydrolase increases coronary perfusion in mice
por: Qin, Jun, et al.
Publicado: (2015)

Dysregulation of Soluble Epoxide Hydrolase and Lipidomic Profiles in Anorexia Nervosa
por: Shih, Pei-an Betty, et al.
Publicado: (2015)

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent Vasodilators
por: Tripathi, Neetika, et al.
Publicado: (2018)

Soluble Epoxide Hydrolase Inhibition for Ocular Diseases: Vision for the Future
por: Park, Bomina, et al.
Publicado: (2019)

Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis
por: McReynolds, Cindy B., et al.
Publicado: (2019)

Soluble Epoxide Hydrolase as a Therapeutic Target for Neuropsychiatric Disorders
por: Shan, Jiajing, et al.
Publicado: (2022)

Inhibitory Activity of Quaternary Isoquinoline Alkaloids on Soluble Epoxide Hydrolase
por: Kim, Jang Hoon, et al.
Publicado: (2022)

Inhibition of Soluble Epoxide Hydrolase Activity by Components of Glycyrrhiza uralensis
por: Kim, Jang Hoon, et al.
Publicado: (2023)

Soluble epoxide hydrolase inhibitor promotes the healing of oral ulcers
por: Li, Juanjuan, et al.
Publicado: (2023)

Quinazoline-4(3H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition
por: Turanlı, Sümeyye, et al.
Publicado: (2022)

In vitro and in vivo Metabolism of a Potent Inhibitor of Soluble Epoxide Hydrolase, 1-(1-Propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea
por: Wan, Debin, et al.
Publicado: (2019)

Role of Endothelial Soluble Epoxide Hydrolase in Cerebrovascular Function and Ischemic Injury
por: Zhang, Wenri, et al.
Publicado: (2013)

Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice
por: Zhu, Ye, et al.
Publicado: (2016)

Exploring the origins of selectivity in soluble epoxide hydrolase from Bacillus megaterium
por: Serrano-Hervás, Eila, et al.
Publicado: (2017)

Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders
por: Hashimoto, Kenji
Publicado: (2019)

Vascular repair and anti-inflammatory effects of soluble epoxide hydrolase inhibitor
por: Dai, Na, et al.
Publicado: (2019)

Selection of Potent Inhibitors of Soluble Epoxide Hydrolase for Usage in Veterinary Medicine
por: Shihadih, Diyala S., et al.
Publicado: (2020)

Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer’s disease
por: Lee, Hsueh-Te, et al.
Publicado: (2019)

Age and Sex Differences in Hearts of Soluble Epoxide Hydrolase Null Mice
por: Jamieson, K. Lockhart, et al.
Publicado: (2020)

Redox Regulation of Soluble Epoxide Hydrolase—Implications for Cardiovascular Health and Disease
por: Charles, Rebecca, et al.
Publicado: (2022)

Decreased Expression of Soluble Epoxide Hydrolase Suppresses Murine Choroidal Neovascularization
por: Park, Bomina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4vatnljmoi8uij0kib2av6hfot